MedTrace Logo

Evaluation of Lactate in Patients Undergoing Glial and Non Glial Mass Surgery With Craniotomy

NCT04584827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-19

No results posted yet for this study

Summary

The aim of this study is to determine the effects of the level of metabolites used in routine on mortality and morbidity in patients who will undergo intracranial surgery with craniotomy.

Conditions

Interventions

OTHER

lactate level

Lactate, a byproduct of glycolysis, is an indicator of weak tissue perfusion and a useful biomarker with prognostic value in various diseases. Lactate value is calculated by blood gas.

OTHER

Glasgow Outcome Scale

Glasgow Outcome Scale; It is a scale developed to categorize people suffering from head trauma or non-traumatic acute brain injury into broad outcome categories. It shows postoperative mortality and morbidity of patients who underwent intracranial surgery.

Sponsors & Collaborators

  • Trakya University

    lead OTHER

Principal Investigators

  • SEVTAP HEKİMOĞLU ŞAHİN, Professor · Trakya University

  • ONUR KÜÇÜK, Resident · Trakya University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2021-12-10
Completion
2022-07-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584827 on ClinicalTrials.gov